is glp-1 safe if you don't have diabetes medications were first developed to treat type 2 diabetes, not obesity., Appetite suppression the effect patients feel. But insulin regulation, glucagon suppression, and gastric slowing are Comparing Ozempic, Wegovy and Other

10.3389/fphar.2020.600175 Summary Keywords anti-inflammatory effects, clinical applications, GLP-1RAs, liver injury, metabolic regulation Citation Hu Z, Tian D, Yang Z, Zhang J, Zhang L, Xu Y and Lu X (2026) The mechanisms of GLP-1 receptor agonists in liver diseases: their multifaceted impact on immune response and metabolic regulation

CDC [Internet]

Structurally, Retatrutide is derived from the glucagon peptide backbone and incorporates targeted amino acid substitutions that improve resistance to enzymatic degradation while maintaining receptor binding capability

Retatrutide is used in vitro to study the combined pharmacology of incretin (GLP-1, GIP) and glucagon receptor signalling in a single molecule

Repeated injections in one location can cause lipohypertrophy (thickened fatty tissue) or lipodystrophy, which affects peptide absorption and creates visible bumps

"Look at the results objectively at every stage: If you're gaining weight back, it's an indication your body needs the higher dose," she says